Glenmark Pharma drops 5% on U.S. FDA warning for Goa facility
The U.S. drug regulator has pointed out various lapses at Glenmark Pharma’s Goa facility, which produces drug formulations.
The U.S. drug regulator has pointed out various lapses at Glenmark Pharma’s Goa facility, which produces drug formulations.